Market Overview

Golden Nugget to Acquire Ameristar Casino Lake Charles Development Project from Pinnacle Entertainment

Share:

Golden Nugget and Pinnacle Entertainment, Inc. (NYSE: PNK) announced today that the companies have entered into a definitive agreement whereby Golden Nugget will acquire all of the equity interests of the entity that owns the Ameristar Casino Lake Charles development project.

Under the terms of the agreement, Golden Nugget will pay total consideration equal to all cash expenditures on the development up until the date of closing, and the assumption of all outstanding payables related to the project at that time, less a $37 million credit. Golden Nugget will complete the development project following the closing of the transaction. Ameristar has disclosed that through June 30, 2013, it had invested total capital of $213.9 million in the Lake Charles project, including the original purchase price, capital expenditures and escrow deposits.

Tilman J. Fertitta, Owner and Chief Executive Officer of Golden Nugget and affiliate, Landry's, Inc., commented, "We are tremendously excited about this opportunity. Due to our strong presence with all of our brands in the Texas and Louisiana markets, we are confident that we can grow gaming revenues in Lake Charles, and together with L'Auberge Lake Charles Casino Resort, offer consumers one of the

See full press release

Posted-In: News Guidance Contracts Global

 

Related Articles (PNK)

View Comments and Join the Discussion!
Need corporate guidance data?
Click here to see licensing options.
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Curis Initiates Clinical Trial of CUDC-427 In Advanced Malignancies

Benzinga Market Primer: Thursday, July 25: Futures Lower After Technical Breakdown